Incidence of and factors associated with achieving target lipid levels in patients with peripheral arterial disease

MR Banta, F Ma, DM Bravata… - Journal of general …, 2006 - Wiley Online Library
BACKGROUND: Patients with peripheral arterial disease (PAD) have increased mortality
compared with patients without PAD. Coronary artery disease (CAD) accounts for almost …

Lipid-lowering therapy in patients with peripheral arterial disease: are guidelines being met?

DG Federman, DC Ranani, RS Kirsner… - Mayo Clinic …, 2005 - Elsevier
OBJECTIVE To determine the proportion of patients with lower extremity peripheral arterial
disease (PAD) who reach recommended low-density lipoprotein cholesterol (LDL-C) levels …

Comparison of lipid management in patients with coronary versus peripheral arterial disease

S Sharma, R Thapa, V Jeevanantham, T Myers… - The American Journal of …, 2014 - Elsevier
Peripheral arterial disease (PAD), similar to coronary artery disease (CAD), is a significant
predictor of cardiovascular morbidity and mortality. Guidelines recommend a low-density …

Effectiveness of blood lipid management in patients with peripheral artery disease

CN Hess, CP Cannon, JA Beckman… - Journal of the American …, 2021 - jacc.org
Background Low-density lipoprotein cholesterol (LDL-C) is associated with heightened risk
of major adverse cardiovascular events (MACE) and major adverse limb events (MALE) in …

[HTML][HTML] Effect of a clinical pharmacy service on lipid control in patients with peripheral arterial disease

TF Rehring, RS Stolcpart, BG Sandhoff… - Journal of vascular …, 2006 - Elsevier
OBJECTIVE: Our group and others have previously established that patients with peripheral
artery disease (PAD) are significantly undertreated with respect to overall cardiovascular risk …

Poor attainment of lipid targets in patients with symptomatic peripheral artery disease

JF Dopheide, L Papac, M Schindewolf… - Journal of clinical …, 2018 - Elsevier
Background Patients with peripheral artery disease (PAD) are at very high risk of future
cardiovascular (CV) events. Strict lipid-lowering therapy is recommended. However, data on …

Lipid management in people with peripheral artery disease

J Golledge, NC Ward, GF Watts - Current Opinion in Lipidology, 2019 - journals.lww.com
Effective methods to educate physicians and patients on best medical management are
needed. Further research is needed to examine the benefit of LDL-c lowering and other lipid …

[HTML][HTML] Atherosclerotic risk factor control in patients with peripheral arterial disease

TF Rehring, BG Sandhoff, RS Stolcpart… - Journal of vascular …, 2005 - Elsevier
BACKGROUND: The presence of peripheral arterial disease (PAD), even in the absence of
overt coronary artery disease (CAD), confers the same relative risk of death from a …

Undertreatment of dyslipidemia in peripheral arterial disease and other high-risk populations: an opportunity for cardiovascular disease reduction

AT Hirsch, AM Gotto Jr - Vascular Medicine, 2002 - journals.sagepub.com
Atherosclerosis is a form of arterial disease that manifests in the coronary circulation as
coronary artery disease (CAD), in the carotid arteries as cerebrovascular disease, and in the …

Peripheral arterial disease and progression of coronary atherosclerosis

AA Hussein, K Uno, K Wolski, S Kapadia… - Journal of the American …, 2011 - jacc.org
Objectives: The purpose of this analysis was to characterize the progression of coronary
atherosclerosis in patients with concomitant peripheral arterial disease (PAD). Background …